Previous
Previous Product Image

Vylda Tablet

195.45 /-
Next

Wonride M 2mg Tablet

66.00 /-
Next Product Image

WARF 1 Tablet

82.65 /-

Salt Composition
Warfarin (1mg)

Marketed By
Cipla Ltd.

Warf 1 Tablet is an oral anticoagulant used to prevent the formation of harmful blood clots in the body. It is commonly prescribed for conditions such as deep vein thrombosis, pulmonary embolism, and stroke prevention. By preventing clot formation, this medication helps reduce the risk of complications associated with blood clots in the legs, lungs, brain, and heart.

Add to Wishlist
Description

Description

Warf 1 Tablet is an oral anticoagulant used to prevent the formation of harmful blood clots in the body. It is commonly prescribed for conditions such as deep vein thrombosis, pulmonary embolism, and stroke prevention. By preventing clot formation, this medication helps reduce the risk of complications associated with blood clots in the legs, lungs, brain, and heart.

Salt Composition
Warfarin (1mg)

How to Use
Take Warf 1 Tablet as prescribed by your doctor. It can be taken with or without food, but it is advisable to take it at a fixed time each day. Swallow the tablet whole and avoid chewing, crushing, or breaking it. Do not stop taking this medication abruptly without consulting your doctor.

Uses/Benefits

  • Prevents deep vein thrombosis (DVT)
  • Helps manage pulmonary embolism
  • Reduces the risk of stroke
  • Prevents the formation of harmful blood clots in the body

Side Effects
Common side effects include:

  • Bleeding
    While most side effects are minor and resolve as your body adjusts to the medication, any persistent or concerning symptoms should be discussed with your doctor. Immediate medical attention is needed if you notice unusual bleeding or blood in your urine, vomit, or stool.

Restrictions

  • Avoid consuming alcohol while on Warf 1 Tablet, as it is unsafe to combine the two
  • Warf 1 Tablet is not recommended during pregnancy due to potential risks to the developing baby
  • Safe to use while breastfeeding under medical guidance, as studies show minimal risk to the baby
  • May be taken by individuals with kidney disease, but regular monitoring is advised
  • Use with caution in individuals with liver disease, and dose adjustment may be necessary

Marketed By
Cipla Ltd.

Shopping cart

1

Subtotal: 1,071.43 (ex. VAT)

View cartCheckout